ArticleScientific reports2026
Development and validation of a machine learning-based prediction model for thrombocytopenia following cardiopulmonary bypass.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Determinants of thrombocytopenia in critically ill patients: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Postoperative thrombocytopenia (TP) is a serious complication of cardiopulmonary bypass (CPB). An accurate prediction model is crucial for the early identification of high-risk patients. This study aimed to develop and validate a prediction model for TP following CPB using machine learning (ML) algorithms combined with least absolute shrinkage and selection operator (LASSO) regression for variable selection. Using a large public database, patients admitted to the intensive care unit (ICU) following initial CPB were included. Clinical demographics, outcomes, and biochemical marker data were collected to identify key variables affecting TP. Prediction models were constructed with four different ML approaches, and model performance was externally validated. Both ICU stay and total hospitalization were longer, and the mortality rate was higher in the TP group than in the non-TP group. LASSO regression identified 10 key predictive variables. The Extreme Gradient Boosting model performed the best, demonstrating strong performance in both internal validation (area under the curve [AUC] = 0.841) and external validation (AUC = 0.795). Platelet count at ICU admission and lactate levels were among the key factors influencing TP risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.